Insider Transactions

What Propanc Biopharma Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Nathanielsz James Andrew	CEO/CFO	Aug 17	Grant / award · A	+2,800,000	—	—	2,800,000
Nathanielsz James Andrew	CEO/CFO	Aug 17	Grant / award · A	+5,928,000	—	—	5,928,004
Kenyon Julian Norman	Chief Scientific Officer	Aug 17	Grant / award · A	+3,420,000	—	—	3,420,005
Kenyon Julian Norman	Director	Feb 04	Other Transaction · J	+17,654,470	—	—	28,466,534
Nathanielsz James Andrew	CEO, CFO, Secretary, Treasurer	Feb 04	Other Transaction · J	+33,259,350	—	—	42,711,111
Nathanielsz James Andrew	Chief Executive Officer	Jul 05	Open-market sale · S	−55,000	$0.09	−$4.98K	9,701,761
Nathanielsz James Andrew	Chief Executive Officer	Jan 23	Open-market sale · S	−15,000	$0.20	−$3K	9,756,761
Nathanielsz James Andrew	Chief Executive Officer	Dec 13	Open-market sale · S	−5,500	$0.20	−$1.1K	9,771,761
Nathanielsz James Andrew	Chief Executive Officer	Sep 14	Open-market sale · S	−5,000	$0.20	−$1K	9,777,261
Nathanielsz James Andrew	Chief Executive Officer	Sep 04	Open-market sale · S	−250,000	$0.20	−$50K	9,782,261
Nathanielsz James Andrew	Chief Executive Officer	Aug 23	Open-market buy · P	−250,000	$0.20	−$50K	9,782,261

Page 1 of 1 · showing the 11 most recent Sign up free to view all 11 transactions and filter by insider →

Comments